Seattle Genetics CEO Clay Siegall: An Interview With “The Pink Sheet” DAILY (Part 2 Of 2)

Biotech chief exec addresses Seattle Genetics’ commercialization strategy and foray outside of oncology.

More from Archive

More from Pink Sheet